PhaseRx, Inc.
PZRX
PZRX was delisted on the 2nd of February, 2018.
0 hedge funds and large institutions have $0 invested in PhaseRx, Inc. in 2018 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $25 → $0 (-$25)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$25 |
PZRX Hedge Fund Activity: Q2 2018 in Review
0 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in PhaseRx, Inc. (PZRX) for Q2 2018, worth a combined $0 — down 100% from $25 a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of PZRX and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Federation des caisses Desjardins du Quebec, exiting entirely with an estimated $25 sold.
- 0 institutional investors held PhaseRx, Inc. (PZRX) as of Q2 2018, down from 1 in Q1 2018.
- Funds reported $0 of PhaseRx, Inc. stock for Q2 2018, down 100% quarter-over-quarter.
- 0 funds opened new PhaseRx, Inc. positions in Q2 2018 and 1 closed out, a net change of -1 holder.
- The largest PhaseRx, Inc. seller in Q2 2018 was Federation des caisses Desjardins du Quebec, an estimated $25 sold.
Based on aggregated 13F filings for Q2 2018.